Issue 12/2013
Content (16 Articles)
Osteoporosis epidemiology in UK Biobank: a unique opportunity for international researchers
N. C. Harvey, P. Matthews, R. Collins, C. Cooper
Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group
M. Hiligsmann, M. Salas, D. A. Hughes, E. Manias, F. H. Gwadry-Sridhar, P. Linck, W. Cowell
Cancer-associated bone disease
R. Rizzoli, J.-J. Body, M.-L. Brandi, J. Cannata-Andia, D. Chappard, A. El Maghraoui, C. C. Glüer, D. Kendler, N. Napoli, A. Papaioannou, D. D. Pierroz, M. Rahme, C. H. Van Poznak, T. J. de Villiers, G. El Hajj Fuleihan
What’s in a name revisited: should osteoporosis and sarcopenia be considered components of “dysmobility syndrome?”
N. Binkley, D. Krueger, B. Buehring
Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women
S. H. Ahn, S. H. Lee, B.-J. Kim, K.-H. Lim, S. J. Bae, E. H. Kim, H.-K. Kim, J. W. Choe, J.-M. Koh, G. S. Kim
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis
P. Farahmand, F. Marin, F. Hawkins, R. Möricke, J. D. Ringe, C.-C. Glüer, N. Papaioannou, S. Minisola, G. Martínez, J. M. Nolla, C. Niedhart, N. Guañabens, R. Nuti, E. Martín-Mola, F. Thomasius, J. Peña, C. Graeff, G. Kapetanos, H. Petto, A. Gentzel, A. Reisinger, P. K. Zysset
Hip fracture prevention with a multifactorial educational program in elderly community-dwelling Finnish women
T. Pekkarinen, E. Löyttyniemi, M. Välimäki
Albuminuria is associated with hip fracture risk in older adults: the cardiovascular health study
J. I. Barzilay, P. Bůžková, Z. Chen, I. H. de Boer, L. Carbone, N. N. Rassouli, H. A. Fink, J. A. Robbins
Fear of falling, fracture history, and comorbidities are associated with health-related quality of life among European and US women with osteoporosis in a large international study
F. Guillemin, L. Martinez, M. Calvert, C. Cooper, T. Ganiats, M. Gitlin, R. Horne, A. Marciniak, J. Pfeilschifter, S. Shepherd, A. Tosteson, S. Wade, D. Macarios, N. Freemantle
Actions of osteoporosis treatments on bone histomorphometric remodeling: a two-fold principal component analysis
X. Wan, Y. Zhao, R. Burge, Y. Jiang
The intravertebral distribution of bone density: correspondence to intervertebral disc health and implications for vertebral strength
A. I. Hussein, T. M. Jackman, S. R. Morgan, G. D. Barest, E. F. Morgan
Adherence to a Mediterranean diet and risk of fractures in French older persons
C. Feart, S. Lorrain, V. Ginder Coupez, C. Samieri, L. Letenneur, D. Paineau, P. Barberger-Gateau
Implications of local osteoporosis on the efficacy of anti-resorptive drug treatment: a 3-year follow-up finite element study in risedronate-treated women
D. Anitha, K. J. Kim, S.-K. Lim, T. Lee
Fibroblast growth factor 21 (FGF21) and bone: is there a relationship in humans?
P. Lee, J. Linderman, S. Smith, R. J. Brychta, R. Perron, C. Idelson, C. D. Werner, K. Y. Chen, F. S. Celi
Osteoporosis in Rett syndrome: a case study presenting a novel management intervention for severe osteoporosis
M. Lotan, R. Reves-Siesel, R. S. Eliav-Shalev, J. Merrick